PMID: 9424978Jan 10, 1998Paper

Hydroxyurea-induced leg ulceration in 14 patients

Annals of Internal Medicine
P J BestR M Petitt

Abstract

Hydroxyurea is an antineoplastic agent commonly used to treat myeloproliferative disorders and other nonneoplastic conditions. To further define the typical features of hydroxyurea-related cutaneous ulcers of the leg. Retrospective, descriptive study of the medical records of patients who developed leg ulcers while receiving hydroxyurea therapy. A tertiary care medical center. Patients with myeloproliferative disorders who were treated with hydroxyurea. 14 patients with extremely painful leg ulcers were identified. The most common ulcer site was the malleoli. Multiple ulcers were seen in 64% of patients. Patients had received hydroxyurea for an average of 6 years before ulcers developed. All ulcers healed after discontinuation of hydroxyurea treatment, and 2 patients developed ulcers after treatment was restarted. Hydroxyurea induces painful leg ulcers that are usually difficult to treat and require cessation of hydroxyurea therapy.

Citations

Nov 15, 2002·International Journal of Hematology·Ruben A Mesa
Nov 15, 2002·International Journal of Hematology·Tiziano Barbui
Jun 29, 2006·Aging Clinical and Experimental Research·Elisabetta RuzzonFabrizio Fabris
Sep 19, 2009·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S BonebergerT Ruzicka
Apr 20, 2011·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·J Dissemond
Jan 12, 1999·Disease-a-month : DM·H W HorowitzG P Wormser
May 5, 1999·Critical Reviews in Oncology/hematology·T Barbui, G Finazzi
Oct 16, 1999·British Journal of Haematology·O Castro
Nov 28, 2001·Clinical and Experimental Dermatology·H S YoungE J Stewart
Feb 13, 2001·International Journal of Dermatology·S K LaughonJ R Nunley
Dec 21, 2002·International Journal of Dermatology·Zeynep DemirçayCafer Adigüzel
Jun 22, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C ZalaJ S Montaner
Sep 11, 2003·Journal of Hematotherapy & Stem Cell Research·Ana María Bravo BlancoMaría Obdulia Vazquez
Sep 12, 2001·Medicine·M H Steinberg, G P Rodgers
Jul 10, 1999·Current Opinion in Hematology·U R Osarogiagbon, P B McGlave
Jul 29, 2000·Australian and New Zealand Journal of Medicine·C McLintock, P A Ockelford
Sep 13, 2000·Drugs & Aging·P J van Genderen, M M Troost
Oct 8, 1999·Leukemia & Lymphoma·F Ravandi-KashaniH Kantarjian
Jan 5, 2001·Expert Opinion on Investigational Drugs·M H Steinberg, T E Mitchell
Aug 21, 2013·The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons·Victoria K ShanmugamJohn S Steinberg
Oct 2, 2012·Dermatologic Clinics·Joshua W HagenA Neil Crowson
Nov 18, 1998·Mayo Clinic Proceedings·G J Ruiz-ArgüellesS G Chernoff
Sep 24, 2005·Mayo Clinic Proceedings·Ayalew Tefferi, Tiziano Barbui
May 27, 2009·Hematological Oncology·Gunnar Birgegård
Jun 8, 2013·Dermatologic Therapy·Mark D Hoffman
Oct 4, 2015·Clinical Lymphoma, Myeloma & Leukemia·Emanuele CozzaniAurora Parodi
Jun 20, 2006·Best Practice & Research. Clinical Haematology·Ruben A MesaAyalew Tefferi
Oct 11, 2005·Hematology/oncology Clinics of North America·Graham R SerjeantAndrea Clare
Jul 14, 2005·Platelets·Maria Luigia RandiFabrizio Fabris
Jan 30, 2007·Journal of Vascular Surgery·Nicos LabropoulosAthanasios D Giannoukas
Nov 21, 2001·Japanese Journal of Cancer Research : Gann·K SakanoS Kawanishi
Aug 17, 2016·Annales de dermatologie et de vénéréologie·A RogerE Mahé
Sep 30, 2000·Clinical and Laboratory Haematology·H S YoungI H Coulson
Nov 27, 2007·Current Problems in Surgery·Michael G FranzMartin C Robson
Oct 27, 1998·Mayo Clinic Proceedings·P J Best, R M Petitt
Mar 26, 2003·The British Journal of Dermatology·J R MekkesJ D Bos
Dec 4, 2004·Pediatric Dermatology·Omid ZargariMaryam Jafroodi
Apr 12, 2003·Leukemia & Lymphoma·H Al-ZahraniJ H Lipton
Nov 25, 2000·Hospital Medicine·J Murphy, S M Morley
Jan 12, 2000·American Journal of Hematology·N YasudaT Usui
Mar 14, 2018·The American Journal of Dermatopathology·Heather ReaginJoseph Susa
Feb 1, 2009·Annals of Dermatology·Seon-Wook HwangHo-Suk Sung
Feb 16, 2006·Journal of Korean Medical Science·Kavitha SaravuJoseph Thomas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Dermatology
M E SirieixJ P Denoeux
Journal of the American Academy of Dermatology
G WeinlichP Fritsch
Archives of Dermatology
B J KennedyR W Goltz
© 2021 Meta ULC. All rights reserved